Emerging therapies for glioblastoma: current state and future directions
L Rong, N Li, Z Zhang - Journal of Experimental & Clinical Cancer …, 2022 - Springer
Glioblastoma (GBM) is the most common high-grade primary malignant brain tumor with an
extremely poor prognosis. Given the poor survival with currently approved treatments for …
extremely poor prognosis. Given the poor survival with currently approved treatments for …
The emerging field of oncolytic virus-based cancer immunotherapy
Oncolytic viruses (OVs) provide novel and promising therapeutic options for patients with
cancers resistant to traditional therapies. Natural or genetically modified OVs are …
cancers resistant to traditional therapies. Natural or genetically modified OVs are …
Immunotherapy: a promising approach for glioma treatment
F Yasinjan, Y **ng, H Geng, R Guo, L Yang… - Frontiers in …, 2023 - frontiersin.org
Gliomas are the most prevalent primary malignant brain tumors worldwide, with
glioblastoma (GBM) being the most common and aggressive type. Despite two decades of …
glioblastoma (GBM) being the most common and aggressive type. Despite two decades of …
[HTML][HTML] Immunotherapy for glioma: current management and future application
Gliomas are intrinsic brain tumors that originate from neuroglial progenitor cells.
Conventional therapies, including surgery, chemotherapy, and radiotherapy, have achieved …
Conventional therapies, including surgery, chemotherapy, and radiotherapy, have achieved …
Glioblastoma therapy: Past, present and future
Glioblastoma (GB) stands out as the most prevalent and lethal form of brain cancer.
Although great efforts have been made by clinicians and researchers, no significant …
Although great efforts have been made by clinicians and researchers, no significant …
Current state of immunotherapy for glioblastoma
Glioma is the most common primary cancer of the central nervous system, and around 50%
of patients present with the most aggressive form of the disease, glioblastoma. Conventional …
of patients present with the most aggressive form of the disease, glioblastoma. Conventional …
Glioma diagnosis and therapy: current challenges and nanomaterial-based solutions
Glioma is often referred to as one of the most dreadful central nervous system (CNS)-specific
tumors with rapidly-proliferating cancerous glial cells, accounting for nearly half of the brain …
tumors with rapidly-proliferating cancerous glial cells, accounting for nearly half of the brain …
Advances in immunotherapy for glioblastoma multiforme
Glioblastoma multiforme (GBM) is the most common and aggressive malignant brain tumor
of the central nervous system and has a very poor prognosis. The current standard of care …
of the central nervous system and has a very poor prognosis. The current standard of care …
Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial
Background Malignant glioma is the most common and lethal primary brain tumour, with
dismal survival rates and no effective treatment. We examined the safety and activity of NSC …
dismal survival rates and no effective treatment. We examined the safety and activity of NSC …
Recent developments in glioblastoma therapy: oncolytic viruses and emerging future strategies
Glioblastoma is the most aggressive form of malignant brain tumor. Standard treatment
protocols and traditional immunotherapy are poorly effective as they do not significantly …
protocols and traditional immunotherapy are poorly effective as they do not significantly …